Concepedia

Chondrolectin Is a Novel Diagnostic Biomarker and a Therapeutic Target for Lung Cancer

Ken Masuda, Atsushi Takano, Hideto Oshita, Hirohiko Akiyama, Eiju Tsuchiya, Nobuoki Kohno, Yusuke Nakamura, Yataro Daigo

Clinical Cancer Research · 2011 · 23 citations · 44 references

DOIFull text

Open access

Abstract

CHODL is likely to be a prognostic biomarker in the clinic and targeting CHODL might be a strategy for the development of anticancer drugs.

References

44

Cancer Statistics, 2009

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2009 · 9.7K citations · Full text

, , +18

Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

Joan H. Schiller, David Harrington, Chandra P. Belani et al. · New England Journal of Medicine · 2002 · 4.9K citations

COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER

J Oan H. S Chiller, D Avid H Arrington, C Handra P. B Elani et al. · 2002 · 3.7K citations

, , +13

HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres

Elaine M. Dunleavy, Danièle Roche, Hideaki Tagami et al. · Cell · 2009 · 622 citations · Full text

, , +13

Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs

Takefumi Kikuchi, Yataro Daigo, Toyomasa Katagiri et al. · Oncogene · 2003 · 322 citations

, , +12